Technology in the picture: novel method detects chromosome abnormalities in very early embryos

At the Center for Medical Genetics at the UZ Brussel, they developed an innovative method called 'Analysis of Parental Contribution for Aneuploidy Detection' (APCAD). This computational method can be used to more accurately detect chromosome abnormalities in very early embryos. It is a key element in a new and improved version of preimplantation genetic testing for aneuploidy (PGT-A); PGT-A version 3.0. By applying the technique they aim to improve implantation rate and reduce the proportion of miscarriages during in vitro fertilization (IVF) treatments. In addition, it helps couples to gain insight in the genetic quality of the available embryos and their prognosis.

The team is actively looking for companies interested in licensing the patent
pending APCAD technique for implementation in their platform. Contact pieter.verdyck@uzbrussel.be if you are interested.

Read more here.